IMMUSE has been extensively studied, with 15 clinical studies demonstrating its efficacy in supporting immune health Lallemand Health Solutions and Kirin Holdings Company, Limited announced their strategic partnership aimed at enhancing the visibility and market reach of IMMUSE, one of the most documented postbiotics for immune support. This collaboration leverages the distinct[Read More…]